Back to top

Wells Fargo Remains a Buy on Neurocrine (NBIX)

Wells Fargo analyst Mohit Bansal maintained a Buy rating on Neurocrine yesterday and set a price target of $200.00. The company’s shares closed yes...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Neurocrine Biosciences, Inc. (NBIX)